Development of an invasive ductal carcinoma in a contralateral composite nipple graft after an autologous breast reconstruction: a case report.

Autologous breast reconstruction Breast cancer Composite nipple grafting Contralateral breast cancer Deep inferior epigastric perforator flap Donor nipple Invasive cancer of graft Nipple graft Nipple-areola complex reconstruction Reconstructed nipple

Journal

Surgical case reports
ISSN: 2198-7793
Titre abrégé: Surg Case Rep
Pays: Germany
ID NLM: 101662125

Informations de publication

Date de publication:
08 Aug 2020
Historique:
received: 31 01 2020
accepted: 27 07 2020
entrez: 10 8 2020
pubmed: 10 8 2020
medline: 10 8 2020
Statut: epublish

Résumé

Nipple-areola complex (NAC) reconstruction is a technique used in breast reconstructive surgery, which is performed during the final stage of breast reconstruction after total mastectomy of primary breast cancer. Composite nipple grafts utilizing the contralateral NAC are common; however, to our knowledge, there are no reports of new primary invasive ductal carcinoma development within the graft. Here, we describe one such case for the first time. A 54-year-old woman was referred to us by the Department of Plastic and Reconstructive Surgery in our medical center for further evaluation of right nipple erosion. She had undergone total mastectomy of the right breast following a breast cancer diagnosis 15 years ago, at which time tumor biological profiling revealed the following: estrogen receptor (ER), positive; progesterone receptor (PgR), negative; and human epidermal growth factor receptor 2 (HER2), undetermined. She received adjuvant chemotherapy and endocrine therapy. She defaulted endocrine therapy for a few years, and 7 years after surgery, she underwent autologous breast reconstruction with a deep inferior epigastric perforator (DIEP) flap. In the following year, NAC reconstruction was performed using a composite graft technique. Seven years after the NAC reconstruction, erosion appeared on the nipple grafted from its contralateral counterpart; scrape cytology revealed malignancy. The skin on the right side of her chest around the NAC and subcutaneous fat tissue consisted of transferred tissue from the abdomen, as the DIEP flap and grafted nipple were located on the graft skin. The right nipple carcinoma arose from the tissue taken from the left nipple. Magnetic resonance imaging (MRI) or computed tomography showed no malignant findings in the left breast. As the malignant lesion seemed limited to the area around the grafted right nipple on MRI, surgical resection with sufficient lateral and deep margins was performed around the right nipple. Pathological findings revealed invasive ductal carcinoma with comedo ductal components infiltrating the graft skin and underlying adipose tissue. Immunohistochemistry revealed positive for ER, PgR, and HER2. To our knowledge, this is the first case involving the development of invasive ductal carcinoma in a nipple graft constructed on the skin of a DIEP flap, with the origin from the contralateral breast's nipple.

Sections du résumé

BACKGROUND BACKGROUND
Nipple-areola complex (NAC) reconstruction is a technique used in breast reconstructive surgery, which is performed during the final stage of breast reconstruction after total mastectomy of primary breast cancer. Composite nipple grafts utilizing the contralateral NAC are common; however, to our knowledge, there are no reports of new primary invasive ductal carcinoma development within the graft. Here, we describe one such case for the first time.
CASE PRESENTATION METHODS
A 54-year-old woman was referred to us by the Department of Plastic and Reconstructive Surgery in our medical center for further evaluation of right nipple erosion. She had undergone total mastectomy of the right breast following a breast cancer diagnosis 15 years ago, at which time tumor biological profiling revealed the following: estrogen receptor (ER), positive; progesterone receptor (PgR), negative; and human epidermal growth factor receptor 2 (HER2), undetermined. She received adjuvant chemotherapy and endocrine therapy. She defaulted endocrine therapy for a few years, and 7 years after surgery, she underwent autologous breast reconstruction with a deep inferior epigastric perforator (DIEP) flap. In the following year, NAC reconstruction was performed using a composite graft technique. Seven years after the NAC reconstruction, erosion appeared on the nipple grafted from its contralateral counterpart; scrape cytology revealed malignancy. The skin on the right side of her chest around the NAC and subcutaneous fat tissue consisted of transferred tissue from the abdomen, as the DIEP flap and grafted nipple were located on the graft skin. The right nipple carcinoma arose from the tissue taken from the left nipple. Magnetic resonance imaging (MRI) or computed tomography showed no malignant findings in the left breast. As the malignant lesion seemed limited to the area around the grafted right nipple on MRI, surgical resection with sufficient lateral and deep margins was performed around the right nipple. Pathological findings revealed invasive ductal carcinoma with comedo ductal components infiltrating the graft skin and underlying adipose tissue. Immunohistochemistry revealed positive for ER, PgR, and HER2.
CONCLUSIONS CONCLUSIONS
To our knowledge, this is the first case involving the development of invasive ductal carcinoma in a nipple graft constructed on the skin of a DIEP flap, with the origin from the contralateral breast's nipple.

Identifiants

pubmed: 32770432
doi: 10.1186/s40792-020-00962-2
pii: 10.1186/s40792-020-00962-2
pmc: PMC7415053
doi:

Types de publication

Journal Article

Langues

eng

Pagination

203

Références

Eur J Surg Oncol. 2016 Apr;42(4):441-65
pubmed: 26868167
Arch Pathol Lab Med. 2013 Jul;137(7):955-60
pubmed: 23808467
BMC Cancer. 2018 Oct 19;18(1):994
pubmed: 30340548
J Surg Oncol. 2016 Jun;113(8):865-74
pubmed: 26918920
CA Cancer J Clin. 1981 Sep-Oct;31(5):281-3
pubmed: 6269713
Mol Carcinog. 2017 Apr;56(4):1199-1213
pubmed: 27787930
Ann Plast Surg. 1994 Jan;32(1):32-8
pubmed: 8141534
Nat Rev Cancer. 2008 Mar;8(3):180-92
pubmed: 18273037
Surg Gynecol Obstet. 1956 Aug;103(2):185-92
pubmed: 13352143
Histopathology. 2020 Feb 13;:
pubmed: 32056259
Arch Pathol Lab Med. 2018 May;142(5):598-605
pubmed: 29431468
Endocr J. 2009;56(1):1-7
pubmed: 18497452
Cancer Treat Rev. 2001 Feb;27(1):9-18
pubmed: 11237774
CA Cancer J Clin. 1982 May-Jun;32(3):187-8
pubmed: 6804039
Ann Plast Surg. 2008 Feb;60(2):144-5
pubmed: 18216504

Auteurs

Mariko Kimura (M)

Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, 232-0024, Japan. mar016@outlook.jp.
Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan. mar016@outlook.jp.

Kazutaka Narui (K)

Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, 232-0024, Japan.

Hidetaka Shima (H)

Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, 232-0024, Japan.

Shizune Ikejima (S)

Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, 232-0024, Japan.

Mayu Muto (M)

Plastic and Reconstructive Surgery, Yokohama City University Medical Center, Yokohama, Japan.

Toshihiko Satake (T)

Plastic and Reconstructive Surgery, Yokohama City University Medical Center, Yokohama, Japan.

Mikiko Tanabe (M)

Diagnostic Pathology, Yokohama City University Medical Center, Yokohama, Japan.

Yoshiaki Inayama (Y)

Diagnostic Pathology, Yokohama City University Medical Center, Yokohama, Japan.

Shoko Adachi (S)

Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, 232-0024, Japan.

Akimitsu Yamada (A)

Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, 232-0024, Japan.

Kazuhiro Shimada (K)

Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, 232-0024, Japan.

Sadatoshi Sugae (S)

Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Yasushi Ichikawa (Y)

Department of Oncology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Takashi Ishikawa (T)

Department of Breast Oncology and Surgery, Tokyo Medical University, Shinjuku, Tokyo, Japan.

Itaru Endo (I)

Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Classifications MeSH